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A method to identify and quantify chromatin-associated proteins has been developed and
applied to the analysis of changes in chromatin-associated proteins induced by Myc oncop-
rotein expression in human B lymphocytes. Chromatin-enriched fractions were isolated by
differential detergent/salt extraction and analyzed by ICAT reagent labeling, multi-dimen-
sional chromatography and tandem mass spectrometry. Many known chromatin-associated
regulatory factors were identified and quantified. The method will be widely applicable to
various biological systems and reveal changes in chromatin-associated regulatory factors that
underlie biological phenomena. (J Am Soc Mass Spectrom 2003, 14, 696–703) © 2003
American Society for Mass Spectrometry
In eukaryotes, chromosomal DNA is wound aroundcore histone octamers, forming a DNA protein com-plex called chromatin. Chromatin is the site of DNA
replication and gene transcription, two fundamental
cellular functions. Many growth and differentiation
signals ultimately target chromatin to induce alteration
in gene expression or DNA replication. It is well estab-
lished that chromatin-associated regulatory factors
(such as transcription and replication factors) play
central roles in the regulation of cell proliferation,
differentiation, senescence, and death. However, these
proteins are generally expressed at very low levels and
are often difficult to extract from the nucleus, which has
hampered their biochemical analysis.
Quantitative proteome analysis is the global analysis
of protein expression and has a number of advantages
over mRNA expression analysis. It directly focuses on
the actual biological effector molecules and provides
information about biological systems that is not directly
apparent from mRNA analysis. mRNA analysis cannot
predict the modification or subcellular location of en-
coded proteins and there is a considerable discrepancy
between mRNA and protein expression levels in eu-
karyotes [1]. While mRNA analysis generally analyzes
all mRNA species expressed in a cell, proteomics allows
the analysis of subsets of proteins that are enriched in
specific biological contexts (such as organellas and
subcellular fractions). The recently developed ICAT
reagent technology [2, 3] has greatly expanded the
range of proteins that can be analyzed (such as low
abundance, hydrophobic, or highly charged proteins)
and allows the accurate quantification and concurrent
sequence identification of individual proteins in com-
plex mixtures.
We have previously used ICAT reagent technology
to analyze the protein expression changes induced by
the Myc oncoprotein in rat fibroblasts [4]. Myc is a
transcription factor implicated in the genesis of various
human cancers (for reviews see [5–9]) and we have
identified many functionally-related protein expression
changes that may account for the effects of Myc on cell
growth and morphology. These include the reduction
of proteases, induction of protein synthesis pathways,
and upregulation of anabolic enzymes upon Myc ex-
pression, which are predicted to lead to increased cell
mass (cell growth). In addition, we observed a Myc-
induced reduction in the levels of adhesion molecules,
actin network proteins, and Rho pathway proteins,
leading to reduced focal adhesions and actin stress
fibers as well as altered morphology. In these experi-
ments, we used whole cell extracts for global protein
expression analysis, which resulted in the predominant
detection of abundant cytoplasmic proteins. Nuclear
proteins appeared to be underrepresented [4]. To ex-
tend the analysis of Myc-regulated proteins in mamma-
lian cells to nuclear regulatory factors, we developed a
method to identify and quantify chromatin-associated
proteins by the combination of chromatin isolation and
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ICAT reagent analysis. We report here the application
of this method to the quantitative analysis of chromatin-
associated factors in human B lymphocytes that express
a regulatable form of Myc.
Experimental
Cell Culture and Preparation of Chromatin-
Enriched Fractions
P493-6 cells [10], human B lymphocytes expressing
c-Myc in a tetracycline-repressible manner, were cul-
tured in RPMI 1640 medium supplemented with 10%
fetal calf serum (FCS). P493-6 cells were arrested in G1
phase by the addition of 0.1 g/ml tetracycline for 72 h
in the presence of FCS. The cells were washed in PBS.
Half of the cells were transferred to RPMI 1640 medium
with 0.25% FCS to induce Myc expression (Myc-ON)
and the other half were transferred to RPMI 1640
medium with 0.25% FCS and 0.1 g/ml tetracycline to
keep Myc off (Myc-OFF). After eight h, the cells were
harvested and chromatin-enriched fractions were pre-
pared essentially as described [11, 12]. Briefly, 2  108
cells were collected, washed with PBS, and suspended
at 4  107 cells/ml in buffer A (10 mM Hepes [pH 7.9],
10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10%
glycerol, and protease inhibitors). Triton X-100 was
added to 0.1%, the cells were incubated on ice for 8 min,
and nuclei (fraction P1) were collected by centrifugation
(5 min, 1300 g, 4 °C). The supernatant (fraction S1) was
removed and the P1 nuclei were washed once in buffer
A and lysed for 30 min in buffer B (3 mM EDTA, 0.2
mM EGTA, and protease inhibitors) on ice. Insoluble
chromatin (fraction P3) and soluble material (fraction
S3) were separated by centrifugation (5 min, 1700 g,
4 °C). P3 fractions were dissolved in a buffer containing
0.5% SDS and concentrated by acetone precipitation
prior to ICAT reagent labeling. Note that dithiothreitol,
which can inhibit ICAT reagent labeling, was omitted
from chromatin preparation buffers.
ICAT Reagent Labeling and Electrospray-
Ionization Tandem Mass Spectrometry
Chromatin-enriched fractions (1.5 mg each) prepared
from ca. 2  108 cells and dissolved in labeling buffer
(0.5% SDS, 6 M urea, 200 mM Tris [pH 8.3], and 5 mM
EDTA) were reduced with 5 mM tributylphosphine for
30 min at 37 °C and labeled (Myc-OFF: Isotopically-light
ICAT reagent; Myc-ON: isotopically-heavy ICAT re-
agent). The two labeled fractions were combined, pro-
teolyzed to peptides with trypsin, and fractionated by
cation-exchange chromatography. ICAT reagent-la-
beled peptides were purified using the biotin tag
present in the reagent and analyzed by microcapillary
high performance liquid chromatography-tandem mass
spectrometry (LC-MS/MS) as described [2–4, 13].
MS/MS spectra were searched against the NCBI human
protein database. Peptides that displayed SEQUEST
scores2 and delta correlation scores0.1 were further
analyzed by detailed spectral analysis.
Antibodies
Anti-MAP kinase antibody, anti-NIFK antibody, and
anti-RbAp48 antibody were obtained from Drs. Yoshiro
Maru, Yoshihiro Yoneda, and Bruce Stillman, respec-
tively. Anti-ATF-3 antibody (sc-188) and anti-Pax-5
antibody (sc-1974) were obtained from Santa Cruz
Biotechnology.
Results and Discussion
To analyze the changes in chromatin-associated pro-
teins induced by Myc expression, we used the human B
cell line, P493-6, in which Myc can be expressed in a
tetracycline-repressible manner [10]. As shown in Fig-
ure 1a, Myc expression was detectable as early as 4–8 h
after tetracycline withdrawal. To detect early protein
changes induced by Myc, we compared the chromatin
protein expression before and 8 h after induction of Myc
expression (Figure 1b). We fractionated the cells into
soluble (S1) and chromatin-enriched (P3) fractions by a
procedure illustrated in Figure 2a. Chromatin-enriched
fractions represented 11% of the total cellular proteins
under the conditions used (Figure 2b). As shown in
Figure 2c, isolated chromatin-enriched (P3) fractions
consisted of mainly histone proteins (H1, H2A, H2B,
H3, and H4) and numerous minor components. Histone
proteins were absent in soluble fractions. Soluble pro-
teins such as MAP kinase (Figure 2d), SUMO-1, and
Smt3b (data not shown) were predominantly detected
in the soluble fraction. Myc, which is a chromatin-
associated transcription factor, was predominantly de-
tected in the chromatin-enriched fractions (Figure 2d).
These results indicate the validity of subcellular frac-
tionation procedure used.
The chromatin-enriched fractions prepared from
P493-6 cells prior to and 8 h following Myc induction
were labeled with ICAT reagent [Myc-OFF: isotopical-
ly-light ICAT reagent; Myc-ON: isotopically-heavy
ICAT reagent] (Figure 1b). As shown in Figure 2c,
among the five histone species, only histone H3 dis-
played a discrete mobility shift after ICAT reagent
labeling. This is consistent with the fact that only
histone H3 contains cysteines which can be labeled with
ICAT reagent and illustrates the specificity of ICAT
reagent labeling. The two labeled fractions were com-
bined, proteolyzed to peptides, and fractionated by
cation-exchange chromatography. ICAT reagent-la-
beled peptides were purified using the biotin tag
present in the reagent and analyzed by microcapillary
high performance liquid chromatography-tandem mass
spectrometry (LC-MS/MS) [2, 3]. Pairs of isotopically
light- and heavy-labeled peptides are chemically iden-
tical, are easily visualized because they essentially co-
elute, and display an 8 Da mass difference in a mass
spectrometer. The relative quantification of each pep-
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tide was determined by the ratio of signal intensities of
peptide pairs using the Express software tool [4]. The
sequence identity of the proteins in the sample was
determined by correlating the tandem mass spectra of
peptides with the NCBI protein database using the Se-
quest algorithm [14]. Together, Express and Sequest per-
mit determination of the relative expression levels (fold
increase or decrease) and the identification of the proteins.
A total of 282 proteins were identified and quanti-
fied, and of these, 64 were known nuclear proteins.
These are listed in Table 1. We also detected 74 pres-
ently uncharacterized proteins that have been identified
by cDNA sequencing projects, whose localization re-
mains to be determined. Cytoplasmic proteins such as
-actin and myosin were also identified. These proteins
may represent contamination by cytoplasmic proteins
of the chromatin-enriched fractions. However, the pres-
ence of a number of these proteins in chromatin has not
been clearly ruled out and it is possible that detection of
these predominantly cytoplasmic proteins in chromatin
fractions may be of some biological significance. For
example, actin and actin-related proteins have recently
been implicated in nuclear functions such as chromatin
remodeling [15].
Figure 1. Analysis of chromatin protein changes in human B cells upon Myc expression. (a)
Induction of Myc expression upon tetracycline withdrawal. 30 g each of the whole cell lysates
prepared from P493-6 cells grown in the presence of 0.1 g/ml tetracycline (pre) or the cells at the
indicated time after removal of tetracycline were analyzed for Myc protein expression by anti-Myc
immunoblotting. The position of the Myc protein is indicated by the arrow. (b) General procedure for
ICAT reagent analysis of chromatin proteins upon Myc expression in P493-6 cells.
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Figure 2. Preparation of chromatin-enriched fractions. (a) Cell fractionation scheme. (b) Yield of the
subcellular fractions. From 2  108 P493-6 cells, 1.5 mg of chromatin-enriched fraction was obtained,
which represented 11% of the total cellular proteins. (c) Coomassie staining of the subcellular
fractions. The soluble (S1) fractions and chromatin-enriched (P3) fractions before acetone precipitation,
after acetone precipitation, or after ICAT reagent labeling were analyzed. The positions of histone
proteins are indicated. Note that among the 5 histone species, only histone H3 displayed a mobility
shift after ICAT reagent labeling. (d) Subcellular fractionation of Myc and MAP kinase. Subcellular
fractions each prepared from 4  105 P493-6 cells were analyzed by immunoblotting. For Myc, the
fractions were prepared as in Figure 1b. For MAPK, subcellular fractions of P493-6 cells growing in
the medium with 10% FCS were used. Arrows indicate the position of Myc or MAPK.
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As shown in Table 1, we were able to identify and
quantify many transcription factors and other chroma-
tin-associated regulatory factors not identified in our
previous whole cell proteome analysis [4]. Histone H3
was not identified by this analysis although it was
efficiently labeled with ICAT reagent (Figure 2c). This is
probably due to the resistance of histones to tryptic
digestion and their highly basic nature, resulting in
irreversible binding to the cation exchange column.
Most of the identified proteins did not display signifi-
cant Myc-induced expression changes possibly because
of the early time point used (only 8 h after Myc
induction). But some proteins displayed significant
expression changes and we have confirmed the reduc-
tion of ATF-3 and induction of NIFK upon Myc expres-
sion by immunoblotting (Figure 3). These protein
changes were confirmed by at least three independent
experiments (data not shown).
ATF-3 is a member of the CREB/ATF family of basic
region leucine zipper transcription factors, which binds
to cAMP responsive element (CRE) and represses tran-
scription [16]. ATF-3 is induced in response to different
stresses such as DNA damage, ischemia, wounding,
and cell death inducing agents, but the consequence of
ATF-3 induction is not well understood [16]. Myc
expression caused a transient reduction of ATF-3 in
chromatin starting as early as 3 h after Myc induction
and ATF-3 expression returned to a basal level (or
higher) at 24 h (Figure 3). The significance of this
transient reduction of ATF-3 upon Myc expression is
currently unclear. However, the very early onset of
ATF-3 reduction upon Myc expression might suggest
some direct regulation. We also observed reduction of
ATF-3 in rat fibroblasts stably expressing Myc, suggest-
ing that the downregulation of ATF-3 by Myc is a
function of Myc common to inducible Myc expression
in human B cells and constitutive Myc expression in rat
fibroblasts (unpublished results).
NIFK is a nucleolar/nuclear protein that was identi-
fied as an interactor of the forkhead associated domain
of Ki-67 nucleolar antigen [17]. Myc expression caused
a gradual increase of NIFK protein levels in chromatin
(Figure 3). Since NIFK is a nucleolar protein that binds
Ki-67, which is a marker of cell proliferation, induction
Figure 3. Immunoblot analysis. 30 g each of the chromatin-enriched (P3) fraction was analyzed.
Mass spectrometric quantification is shown on the right.
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Table 1. Nuclear proteins
Category Protein name
(L):(H)ab
nb Notes
Mye-OFF:Mye-ON
Ratio
Transcription ATF-3 1: 0.10 1 CREB/ATE family transcription factor
NY-BR-1 1: 0.21 1 Nuclear bZip, breast cancer antigen
Dachshund 1: 0.43 1 Human dachschund homologue
NREBP 1: 0.48 1 HBV NRE-binding transcriptional repressor
B3-1 1: 0.82 1 Leucine zipper domain protein
Trithorax 1: 0.83 1 Required for correct expression of homeotic
genes
Pax-5 1: 0.88 1 Bcell specific transcription factor
RNA polymerase II largest subunit 1: 0.88 1
RBP-J kappa 1: 0.98 1 A target of Notch, Notch converts RBP-J kappa to
an activator
CTCF 1: 0.99 1 Transcriptional repressor of the c-myc promoter
Androgen receptor 1: 1.00 1
RFXA 1: 1.08  0.00 2 MHC class II transcription factor
BAZ1B 1: 1.11  0.16 2 Bromodomain adjacent to zinc finger 1B
TFII-I 1: 1.12 1 Implicated in initiator-dependent transcription
Sox-LZ 1: 1.25 1 Transcription factor with leucine zipper and HMG
box
ZFP92 1: 1.33 1 Zinc finger protein 92
Brn-3a 1: 1.64 1 Brain specific homeobox/pou-domain protein 3a
Progesteron receptor 1: 2.10 1
Chromatin DNA topoisomerase II a 1: 0.68  0.02 2
CBP 1: 0.69  0.04 2 Transcriptional coactivator, histone acetyl
transferase
KIF4A 1: 0.89 1 Chromosome associated kinesin
CHD3/Mi-2 1: 0.90 1 DNA helicase, component of Mi-2 histone
deacetylase complex
CHD4/Mi-2 1: 0.90  0.03 2 DNA helicase, component of Mi-2 histone
deacetylase complex
RbAP46 1: 0.91 1 Histone binding protein, recruits HAT, HDAC, and
CAF to histones
CENP-C 1: 0.92  0.10 2 Centromere binding protein
p300 1: 1.00 1 Transcriptional coactivator, histone acetyl
transferase
PARP 1: 1.04  0.065 5 Poly ADP-ribose polymerase
DNA topoisomerase I 1: 1.07  0.08 3
Histone macro h2a.1 1: 1.09  0.03 3 Histone H2A variant enriched in inactive X
chromosome
SMC1 1: 1.18  0.13 4 Component of condensin complex, chromosomal
condensation
RCC1 1: 1.24  0.02 2 Regulator of chromosomal condensation, GEF for
nuclear G-protein, ran
DNA topoisomerase IIb 1: 1.27  0.01 2
RbAP48 1: 1.28 1 Histone binding protein, recruits HAT, HDAC, and
CAF to histones
Replication GANP 1: 1.15  0.10 2 DNA primase that binds MCM-3
DNA repair DNA-PKc 1: 0.76 1 Catalytic subunit of DNA-dependent protein
kinase
XRCC2 1: 0.86 1 Involved in the homologous recombination repair
of double-stranded DNA
53BP1 1: 1.07  0.00 2 p53 binding protein, ATM substrate, involved in
DNA damage signalling
Uracil DNA glycosylase 2 1: 2.03 1 Excises uracil residues from the DNA
Splicing Sip1 1: 1.45 1 SR domain containing splicing factor
Nuclear matrix NMP200 1: 0.76 1 Nuclear matrix protein 200
NMP238 1: 0.78  0.00 2 Nuclear matrix protein 238
Nuclear membrane RanBP2 1: 0.75  0.08 3 Ran-binding protein 2
Nup88 1: 0.82 1 Nuclear pore protein 88
lamin A 1: 0.82  0.01 2 Component of the nuclear lamina
lamin B1 1: 0.92  0.08 5 Component of the nuclear lamina
(continued)
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of NIFK by Myc may have some role in upregulation of
ribosome biogenesis and protein synthesis by Myc.
We have also confirmed that there is little or no
change in the expression levels of B cell specific tran-
scription factor, Pax-5 and histone escort protein,
RbAp48 by immunoblotting (Figure 3).
These results indicate that a combination of chroma-
tin isolation and ICAT reagent analysis allows identifi-
cation and accurate quantification of rare chromatin-
associated regulatory factors.
Our previous analyses indicated that ICAT quantifi-
cation is highly reliable and reproducible [2, 3, 18, 19].
In the case of the analysis of Halobacterium total
protein extracts [18], a second ICAT analysis was
performed wherein the labeling of the two protein
samples was reversed with respect to the light and
heavy ICAT reagents, and essentially the same results
as in the first ICAT analysis were obtained. There is
also a good correlation between ICAT quantification
and quantification by immunoblotting ([4], this pa-
per, and unpublished results). However, since the
ICAT reagent technology is still in the early phase of
development, we would like to suggest that at the
present stage, the method described in this paper
should be regarded as a screening step to identify
potentially interesting chromatin protein changes,
which need to be independently confirmed by immu-
noblotting before they can be considered confirmed
data.
Conclusions
We have developed a method to identify and quantify
chromatin-associated regulatory factors by a combina-
tion of chromatin isolation and ICAT reagent analysis.
Using this method, we have identified many chromatin-
associated proteins and assessed the effect of Myc
expression on their presence in chromatin. Most of the
identified proteins did not display significant expres-
sion changes, suggesting that Myc does not robustly
affect chromatin protein expression. However, some
potentially interesting changes were observed. Chroma-
tin-associated proteins were barely detected in our
previous whole proteome analysis [4], indicating the
necessity of directly analyzing chromatin-enriched frac-
tions for detection of chromatin-associated factors with
the current technology. Our chromatin-ICAT reagent
analysis method will be useful in various biological
systems by identifying changes in chromatin-associated
regulatory factors which underlie biological phenom-
ena. We are now in the process of quantitative analysis of
chromatin proteins during the cell cycle and cell death.
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